TABLE 1 WORLD NEUROMODULATION MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 2 INTERNAL NEUROMODULATION MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 3 EXTERNAL NEUROMODULATION MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 4 WORLD NEUROMODULATION MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 5 NEUROMODULATION MARKET FOR FAILED BACK SYNDROME, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 6 NEUROMODULATION MARKET FOR CHRONIC PAIN, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 7 NEUROMODULATION MARKET FOR EPILEPSY, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 8 NEUROMODULATION MARKET FOR ESSENTIAL TREMOR, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 9 NEUROMODULATION MARKET FOR URINARY AND FECAL INCONTINENCE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 10 NEUROMODULATION MARKET FOR DEPRESSION, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 11 NEUROMODULATION MARKET FOR DYSTONIA, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 12 NEUROMODULATION MARKET FOR GASTROPARESIS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 13 NEUROMODULATION MARKET FOR PARKINSONS DISEASE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 14 NEUROMODULATION MARKET FOR MIGRAINE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 15 NEUROMODULATION MARKET FOR OBSESSIVE-COMPULSIVE DISORDER, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 16 NEUROMODULATION MARKET FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 17 WORLD NEUROMODULATION MARKET, BY BIOMATERIAL, 2014-2022 ($MILLION)
TABLE 18 NEUROMODULATION MARKET FOR CERAMIC BIOMATERIALS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 19 NEUROMODULATION MARKET FOR METALLIC BIOMATERIALS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 20 NEUROMODULATION MARKET FOR POLYMERIC BIOMATERIALS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 21 NEUROMODULATION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 22 NORTH AMERICA NEUROMODULATION MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 23 NORTH AMERICA NEUROMODULATION MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 24 NORTH AMERICA NEUROMODULATION MARKET, BY BIOMATERIAL, 2014-2022 ($MILLION)
TABLE 25 EUROPE NEUROMODULATION MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 26 EUROPE NEUROMODULATION MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 27 EUROPE NEUROMODULATION MARKET, BY BIOMATERIAL, 2014-2022 ($MILLION)
TABLE 28 ASIA-PACIFIC NEUROMODULATION MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 29 ASIA-PACIFIC NEUROMODULATION MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 30 ASIA-PACIFIC NEUROMODULATION MARKET, BY BIOMATERIAL, 2014-2022 ($MILLION)
TABLE 31 LAMEA NEUROMODULATION MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 32 LAMEA NEUROMODULATION MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 33 LAMEA NEUROMODULATION MARKET, BY BIOMATERIAL, 2014-2022 ($MILLION)
TABLE 34 ALEVA: COMPANY SNAPSHOT
TABLE 35 ALEVA: PRODUCT CATEGORIES
TABLE 36 BIOCONTROL MEDICAL: COMPANY SNAPSHOT
TABLE 37 BIOCONTRL MEDICAL: PRODUCT CATEGORIES
TABLE 38 BIONESS: COMPANY SNAPSHOT
TABLE 39 BIONESS: PRODUCT CATEGORIES
TABLE 40 BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 41 BOSTON SCIENTIFIC: PRODUCT CATEGORIES
TABLE 42 ENTEROMEDICSINC: COMPANY SNAPSHOT
TABLE 43 ENTEROMEDICSINC: PRODUCT CATEGORIES
TABLE 44 LIVANOVA: COMPANY SNAPSHOT
TABLE 45 LIVANOVA: PRODUCT CATEGORIES
TABLE 46 MEDTRONIC: COMPANY SNAPSHOT
TABLE 47 MEDTRONIC: OPERATING SEGMENTS
TABLE 48 NEUROPACE: COMPANY SNAPSHOT
TABLE 49 NEVRO: COMPANY SNAPSHOT
TABLE 50 NEVRO: PRODUCT CATEGORIES
TABLE 51 ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 52 ST. JUDE MEDICAL: PRODUCT CATEGORIES

LIST OF FIGURE

FIG. 1 TOP INVESTMENT POCKETS IN WORLD NEUROMODULATION MARKET
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (20142016)
FIG. 3 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 4 PORTERS FIVE FORCES ANALYSIS
FIG. 5 MARKET SHARE ANALYSIS, 2015
FIG. 6 U.S. NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 7 CANADA NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 8 MEXICO NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 9 GERMANY NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 10 FRANCE NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 11 U.K. NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 12 ITALY NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 13 SPAIN NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 14 REST OF EUROPE NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 15 JAPAN NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 16 CHINA NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 17 INDIA NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 18 SOUTH KOREA NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 19 MALAYSIA NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 20 REST OF ASIA-PACIFIC NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 21 BRAZIL NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 22 ISRAEL NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 23 SAUDI ARABIA NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 24 SOUTH AFRICA NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 25 REST OF LAMEA NEUROMODULATION MARKET, 2014-2022 ($MILLION)
FIG. 26 BOSTON SCIENTIFIC: REVENUE, 20132015 ($MILLION)
FIG. 27 BOSTON SCIENTIFIC: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 28 BOSTON SCIENTIFIC: REVENUE, BY SUB SEGMENT, 2015 (%)
FIG. 29 BOSTON SCIENTIFIC: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 30 LIVANOVA: REVENUE, 20132015 ($MILLION)
FIG. 31 LIVANOVA: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 32 LIVANOVA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 33 LIVANOVA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 34 MEDTRONIC: REVENUE, 20142016 ($MILLION)
FIG. 35 MEDTRONIC: REVENUE, BY SEGMENT, 2016 (%)
FIG. 36 MEDTRONIC: CARDIAC AND VASCULAR GROUP REVENUE, BY SUBSEGMENT, 2016 (%)
FIG. 37 MEDTRONIC: REVENUE, BY GEOGRAPHY, 2016 (%)
FIG. 38 NEVRO: REVENUE, 20132015 ($MILLION)
FIG. 39 NEVRO: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 40 ST. JUDE MEDICAL: REVENUE, 20132015 ($MILLION)
FIG. 41 ST. JUDE MEDICAL: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 42 ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHY, 2015 (%)